BIPARBathurst Inlet Port and Road (Canada)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
"This is the forefront of a field that is about to open up, about DNA repair." In that same year, the French pharmaceutical giant Sanofi bought BiPar for $500 million.
BiPar is the leading company in the emerging field of DNA (DeoxyriboNucleic Acid) repair using PARP (Poly ADP-Ribose Polymerase) inhibitors.
Van Gieson, chairman and chief executive of Chubb Insurance Company of Europe, stated at a recent meeting of BIPAR in Washington, D.C., adding that "each country has unique characteristics from the standpoint of competition, products and services, languages and culture." Furthermore, the new measures that brought the single market into existence will only "produce their effects gradually over a period extending well beyond 1994," reported Mr.
Address for correspondence: Muriel Vayssier-Tassat, AFSSA-UMR BIPAR, 23 Rue du General de Gaulle, Maisons-Alfort 94700, France; email:
12 October 2010 - French sanofi-aventis (EPA: SAN) and its subsidiary BiPar Sciences on Sunday said that final results from a randomised Phase II study confirmed that treatment with BSI-201 (iniparib) in combination with gemcitabine/carboplatin results in a significant improvement in overall survival and a high rate of clinical response in women with metastatic triple negative breast cancer (mTNBC).
(Chattanooga TN) and biopharmaceutical company BiPar Sciences Inc.
He also started making acquisitions, including the April purchase of BiPar Sciences Inc.
Address for correspondence: Henri-Jean Boulouis, Unite Mixte de Recherche BIPAR INRA/AFSSA/UPVM/ENVA (Biologie et Immunologie Parasitaires et Fongiques), 23 Avenue du General de Gaulle, 94706, Maisons-Alfort, France; email:
BIPAR has long been calling for EU legislation in this field.
The experimental drug added by Paris-based Sanofi when it bought BiPar Sciences Inc.
Sanofi-aventis has entered an agreement to acquire BiPar Sciences, Inc., a privately held U.S.
Minimum harmonisation and maximum mutual recognition is the option that has won the widest support - from twelve Member States, the European insurance industry association, CEA, and, subject to some qualifications, from European consumers and from the intermediaries' own association, BIPAR. The Commission is continuing to explore how such an approach could work in practice.